5 Mid Cap Losers In Focus: NRF, GT, 3D Systems (NYSE:DDD), CIT Group (NYSE:CIT), ISIS Pharmaceuticals (NASDAQ:ISIS)

Northstar Reality Finance Corp. (NYSE:NRF), is sinking in the market by highs of 7.01% after refuting claims it is planning to merge with American Reality Capital Properties Inc. It was being reported from people with knowledge that American Reality was planning to table an offer of about $20 a share. If American tables this bid, it will represent a 25% premium on Northstar Reality Finance Corp. (NYSE:NRF) closing price of $16.03 as of last week. This should essentially value the company at $6.5 billion. it is also being reported that talks between the two companies are still preliminary according to sources with inside information. North star Realty Finance Corp.(NYSE:NRF) shares after opening at $15.95 moved to $16.31 on last trade day and at the end of the day closed at $15.90. Company price to sales ratio in past twelve months was calculated as -7.50 and price to cash ratio as -1.60. Northstar Realty Finance Corp. (NYSE:NRF) showed a positive weekly performance of 3.92%.

Shares of Goodyear Tire & Rubber (NASDAQ:GT) lost some air after the Ohio company reported a $58 million first-quarter loss largely due to $132 million in Venezuelan currency charges. The loss was compounded by extreme US winter weather that hurt tire sales, the company said. The losses added up to 23 cents per share. It made $26 million, or 10 cents, a year ago. Adjusted earnings came in below Wall Street estimates of 60 cents. Revenue dropped 8 percent to $4.47 billion from $4.85 billion, just short of projections of $4.81 billion. The Goodyear Tire & Rubber Company (NASDAQ:GT) shares fell -7.55% in last trading session and ended the day on $25.11. GT return on equity ratio is recorded as 132.70% and its return on assets is 3.40%. The Goodyear Tire & Rubber Company (NASDAQ:GT) yearly performance is 101.04%.

3D Systems Corporation (NYSE:DDD) ‘ poorly received earnings report sent the shares 9.1% into the red to close at $44.80. Shortly after the opening bell, the stock was placed on the short-sale restricted (SSR) list, helping its overall options volume to skyrocket to 92,000, or three times the expected daily amount. While calls and puts traded at a nearly neck-and-neck pace, the two most active strikes in DDD’s options pits were weekly 5/2 puts, which saw a mix of buy- and sell-to-open activity. From a broader perspective, nine of the 10 most active strikes had expiration dates within the next three weeks. 3D Systems Corporation (NYSE:DDD) shares moved down -9.05% in last trading session and was closed at $44.80, while trading in range of $ 43.35 – 47.50. 3D Systems Corporation (NYSE:DDD) year to date (YTD) performance is -51.79%.

CIT Group (NYSE:CIT) announced its earnings results on Tuesday. The company reported $0.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by $0.31, StockRatingsNetwork.com reports. During the same quarter in the previous year, the company posted $0.81 earnings per share. CIT Group Inc.(NYSE:CIT) weekly performance is -6.64%. On last trading day company shares ended up $43.61. CIT Group Inc. (NYSE:CIT) distance from 50-day simple moving average (SMA50) is -9.38%. Analysts mean target price for the company is $54.69.

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) provided an update on both of its ongoing open-label Phase 2 clinical studies of ISIS-SMNRx in infants and children with spinal muscular atrophy (SMA) at the 66th American Academy of Neurology (AAN) meeting in Philadelphia, PA. Results from Phase 2 study in infants with SMAIn the study in infants with SMA, a total of 15 infants have been dosed as of April 7, four infants in the 6 mg cohort and 11 infants in the 12 mg cohort. The 12 mg cohort is continuing to enroll patients. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) shares after opening at $31.69 moved to $33.24 on last trade day and at the end of the day closed at $29.39. Company price to sales ratio in past twelve months was calculated as 23.40 and price to cash ratio as 4.86. ISIS Pharmaceuticals, Inc.(NASDAQ:ISIS) showed a negative weekly performance of -20.57%.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *